Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool. (Q38253227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

review article

1 reference

title

Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mario Cozzolino

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

A Galassi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

A Santoro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

23 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

published in

Journal of Nephrology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

415-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245472%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40620-014-0142-4

17 February 2020

exact match

0 references

cites work

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Novel bone endocrine networks integrating mineral and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

"Phosphatonins" and the regulation of phosphorus homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Klotho: an antiaging protein involved in mineral and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

The basal rate of cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Transforming growth factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Pathogenesis of vascular calcification in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Calcium and phosphate control by dialysis treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Vascular calcification and uremia: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phytate: impact on environment and human nutrition. A challenge for molecular breeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Management of natural and added dietary phosphorus burden in kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Contribution of food additives to sodium and phosphorus content of diets rich in processed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

The phosphate binder equivalent dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Low socioeconomic status associates with higher serum phosphate irrespective of race

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Nutritional knowledge in hemodialysis patients and nurses: focus on phosphorus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Serum phosphorus in people with chronic kidney disease: you are what you eat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphate elimination in modalities of hemodialysis and peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

The role of daily dialysis in the control of hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Lanthanum carbonate is an effective hypophosphatemic agent for hemodialysis patients intolerant of other phosphate binders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Magnesium: a renewed player of vascular ageing in diabetic CKD patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Age, Renal Tubular Phosphate Reabsorption, and Serum Phosphate Levels in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Mortality in kidney disease patients treated with phosphate binders: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0142-4

Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients

21 January 2018

1 reference

12 December 2020

De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism

1 reference

12 December 2020

Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST)

1 reference

12 December 2020

Effect of phosphate on the parathyroid gland: direct and indirect?

1 reference

12 December 2020

p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth

1 reference

12 December 2020

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

1 reference

12 December 2020

Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients

1 reference

12 December 2020

Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study

1 reference

12 December 2020

EBPG guideline on nutrition

1 reference

12 December 2020

Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response

1 reference

12 December 2020

The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit

1 reference

12 December 2020

[The impact of known and unknown dietary components to phosphorus intake]

1 reference

12 December 2020

Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence

1 reference

12 December 2020

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

12 December 2020

The absorption of dietary phosphorus and calcium in hemodialysis patients

1 reference

12 December 2020

Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients

1 reference

12 December 2020

Phosphorus dynamics during hemodialysis

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells

1 reference

12 December 2020

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients

1 reference

12 December 2020

Phosphate control in chronic uremia: don't forget diet.

1 reference

12 December 2020

Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro

1 reference

12 December 2020

The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction

1 reference

12 December 2020

Demineralization of a wide variety of foods for the renal patient

1 reference

12 December 2020

Effect of boiling on dietary phosphate and nitrogen intake

1 reference

12 December 2020

Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients: A Prospective Study

1 reference

12 December 2020

Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system

1 reference

12 December 2020

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

12 December 2020

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

1 reference

12 December 2020

A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients

1 reference

12 December 2020

Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006

1 reference

12 December 2020

The role of dietary phosphorus restriction in the conservative management of chronic renal disease

1 reference

12 December 2020

Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium

1 reference

12 December 2020

Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights

1 reference

12 December 2020